Measurement of Intermolecular Distances for the Natural Agonist Peptide Docked at the Cholecystokinin Receptor Expressed in Situ Using Fluorescence Resonance Energy Transfer

Molecular Pharmacology

Volumn 65, Issue 1, 2004, Pages 28-35

  Harikumar, Kaleeckal G ^a   Pinon, Delia I ^a   Wessels, William S ^a   Dawson, Eric S ^b   Lybrand, Terry P ^b   Prendergast, Franklyn G ^a   Miller, Laurence J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOETHYLMETHANETHIOSULFONATE; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL LABELING; CHO CELL; CONTROLLED STUDY; CRYSTAL STRUCTURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE CONSTRUCT; INTERMOLECULAR DISTANCE; MEMBRANE STRUCTURE; MOLECULAR MODEL; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CHO CELLS; CHOLECYSTOKININ; CRICETINAE; FLUORESCENCE RESONANCE ENERGY TRANSFER; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, CHOLECYSTOKININ;

EID: 1642454586     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.1.28     Document Type: Article

References (33)

1. Bodanszky M, Natarajan S, Hahne W, and Gardner JD (1977) Cholecystokinin (pancreozymin). 3. Synthesis and properties of an analogue of the C-terminal heptapeptide with serine sulfate replacing tyrosine sulfate. J Med Chem 20:1047-1050.
2. Bodanszky M, Tolle JC, Gardner JD, Walker MD, and Mutt V (1980) Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33. Int J Pept Protein Res 16:402-411.
3. Dawson ES, Henne RM, Miller LJ, and Lybrand TP (2002) Molecular models for cholecystokinin-A receptor. Pharmacol Toxicol 91:290-296.
4. Ding XQ, Dolu V, Hadac EM, Holicky EL, Pinon DI, Lybrand TP, and Miller LJ (2001) Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe. J Biol Chem 276:4236-4244.
5. Ding XQ, Dolu V, Hadac EM, Schuetz M, and Miller LJ (2003) Disulfide bond structure and accessibility of cysteines in the ectodomain of the cholecystokinin receptor: specific mono-reactive receptor constructs examine charge-sensitivity of loop regions. Recept Channel 9:83-91.
6. Ding XQ, Pinon DI, Furse KE, Lybrand TP, and Miller LJ (2002) Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor. Mol Pharmacol 61:1041-1052.
7. Escrieut C, Gigoux V, Archer E, Verrier S, Maigret B, Behrendt R, Moroder L, Bignon E, Silvente-Poirot S, Pradayrol L et al. (2002) The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146, 131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process. J Biol Chem 277:7546-7555.
8. 1H NMR spectroscopy, fluorescence- transfer measurements and calculations. Biochemistry 25:3778-3787.
9. Garzon-Rodriguez W, Sepulveda-Becerra M, Milton S, and Glabe CG (1997) Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J Biol Chem 272:21037-21044.
10. Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N et al. (1999) Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Protein Sci 8:2347-2354.
11. Gregoret LM and Cohen FE (1990) Novel method for the rapid evaluation of packing in protein structures. J Mol Biol 211:959-974.
12. Hadac EM, Ghanekar DV, Holicky EL, Pinon DI, Dougherty RW, and Miller LJ (1996) Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylation. Pancreas 13:130-139.
13. Hadac EM, Ji ZS, Pinon DI, Henne RM, Lybrand TP, and Miller LJ (1999) A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely. J Med Chem 42:2105-2111.
14. Hadac EM, Pinon DI, Ji Z, Holicky EL, Henne R, Lybrand T, and Miller LJ (1998) Direct identification of a second distinct site of contact between cholecystokinin and its receptor. J Biol Chem 273:12988-12993.
15. Harikumar KG, Pinon DI, Wessels WS, Prendergast FG, and Miller LJ (2002) Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor. J Biol Chem 277:18552-18560.
16. Hubbell WL, Altenbach C, Hubbell CM, and Khorana HG (2003) Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity and disulfide cross-linking. Adv Protein Chem 63:243-290.
17. Ji TH, Grossmann M, and Ji I (1998) G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem 273:17299-17302.
18. Ji Z, Hadac EM, Henne RM, Patel SA, Lybrand TP, and Miller LJ (1997) Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling. J Biol Chem 272:24393-24401.
19. Kennedy K, Gigoux V, Escrieut C, Martinez J, Moroder L, Frehel D, Gully D, Vayse N, and Fourmy D (1997) Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin. J Biol Chem 272:2920-2926.
20. Klueppelberg UG, Powers SP, and Miller LJ (1990) The efficiency of covalent labeling of the pancreatic cholecystokinin receptor using a battery of cross-linkable and photolabile probes. Receptor 1:1-11.
21. Lakowicz JR (1980) Fluorescence spectroscopic investigations of the dynamic properties of proteins, membranes and nucleic acids. J Biochem Biophys Method 2:91-119.
22. Laskowski RA, MacArthur MW, Moss DS, and Thornton JM (1993) PROCHECK. J Appl Crystallogr 26:283-291.
23. Li M, Reddy LG, Bennett R, Silva ND Jr, Jones LR, and Thomas DD (1999) A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban. Biophys J 76:2587-2599.
24. 125I-desaminotyrosyl-)CCK-8 and its interactions with pancreatic acini. J Biol Chem 256:12417-12423.
25. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Trong IL, Teller DC, Okada T, Stenkamp RE, et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science (Wash DC) 289:739-745.
26. Panchuk-Voloshina N, Haugland RP, Bishop-Stewart J, Bhalgat MK, Millard PJ, Mao F, Leung WY, and Haugland RP (1999) Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J Histochem Cytochem 47:1179-1188.
27. Rao RV, Roettger BF, Hadac EM, and Miller LJ (1997) Roles of cholecystokinin receptor phosphorylation in agonist-stimulated desensitization of pancreatic acinar cells and receptor-bearing Chinese hamster ovary cholecystokinin receptor cells. Mol Pharmacol 51:185-192.
28. Roettger BF, Hellen EH, Burghardt TP, and Miller LJ (2001) Multiple ligand and cell-dependent states of lateral mobility of plasmalemmal G protein-coupled cholecystokinin receptors. J Fluorescence 11:237-246.
29. Roettger BF, Rentsch RU, Pinon D, Holicky E, Hadac EM, Larkin JM, and Miller LJ (1995) Dual pathways of internalization of the cholecystokinin receptor. J Cell Biol 128:1029-1042.
30. Rosenzweig SA, Miller LJ, and Jamieson JD (1983) Identification and localization of cholecystokinin-binding sites on rat pancreatic plasma membranes and acinar cells: a biochemical and autoradiographic study. J Cell Biol 96:1288-1297.
31. Rye HS (2001) Application of fluorescence resonance energy transfer to the GroEL-GroES chaperonin reaction. Methods 24:278-288.
32. Stryer L and Haugland RP (1967) Energy transfer: a spectroscopic ruler. Proc Natl Acad Sci USA 58:719-726.
33. Vallotton P, Tairi AP, Wohland T, Friedrich-Benet K, Pick H, Hovius R, and Vogel H (2001) Mapping the antagonist binding site of the serotonin type 3 receptor by fluorescence resonance energy transfer. Biochemistry 40:12237-12242.